EvolveImmune Therapeutics logo

EvolveImmune Therapeutics

Reimagining Cancer Immunotherapy

58 employees · est. 2020 · Branford, United States

VS
Kite Pharma logo

Kite Pharma

At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.

4013 employees · est. 2009 · Santa Monica, United States

Kite Pharma is the older company (2020 vs 2009); Kite Pharma is the larger of the two.

Side-by-Side Comparison

EvolveImmune Therapeutics Kite Pharma
Founded
2020 2009 older
Headquarters
Branford, United States Santa Monica, United States
Employees
58 4013 larger
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Health and Wellness
Funding Stage
Series Unknown Acquired
Total Funding
$54.95M $12.56B
Funding Rounds
2 8
Services
Development of trispecific T cell engagers, Partnerships for additional therapeutic development, Clinical trial management Cell Therapy Development, Manufacturing of CAR T-cell Therapies, Clinical Trials and Research, Patient Support and Resources, External Research Programs
Target Customers
Cancer patients, Healthcare institutions, Pharmaceutical companies Cancer Patients, Healthcare Providers, Research Institutions, Biopharmaceutical Investors, Oncology Care Centers
Taxonomy
Cancer Immunotherapy, Trispecific T Cell Engagers, CD2 Costimulation, EVOLVE Platform, Tumor Cell Resistance, Clinical Trials, Immune Activation, Tumor Targeting, Cytokine Secretion Amplification, Biotherapeutics Engineering, CD3 Bispecific Limitations, Immune Therapy Optimization, T-Cell Exhaustion, Immunobiological Platform, Tumor Cell Killing Cell Therapy, Cancer Immunotherapy, Hematologic Malignancies, Engineered T Cell Therapy, Autologous Cell Therapy, Immune-Based Targeted Therapies, Tumor Cell Reengineering, Cancer Treatment Innovation, Patient-Specific Treatments, Biopharmaceutical Manufacturing, T Cells Engineering, Oncology Therapeutics, Immune System Stimulation
Website
evolveimmune.com kitepharma.com
EvolveImmune Therapeutics logo

About EvolveImmune Therapeutics

EvolveImmune Therapeutics, founded in 2020 and headquartered in the United States, is a biotechnology company creating innovative solutions for cancer treatment. Their slogan, "Reimagining Cancer Immunotherapy", reflects their ambitious approach in developing unique trispecific T cell engagers via t...

Kite Pharma logo

About Kite Pharma

Kite Pharma, a subsidiary of Gilead Sciences, is a pioneering company in the Biotechnology, Health Care, and Health and Wellness industries, renowned for its commitment to cell therapy as a remedy for cancer. Founded in 2009, Kite has positioned itself as a leader in engineered T cell therapy for he...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at EvolveImmune Therapeutics and Kite Pharma — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at EvolveImmune Therapeut... and Kite Pharma — by email.

Frequently Asked Questions

EvolveImmune Therapeutics — Reimagining Cancer Immunotherapy. Kite Pharma — At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
EvolveImmune Therapeutics has raised $54.95M while Kite Pharma has raised $12.56B.
EvolveImmune Therapeutics and Kite Pharma operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare EvolveImmune Therapeutics with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy